Page A6 of the Monday June 14th 2010 edition.
MEETING HIGHLIGHTS MEDICAL ADVANCES:by Peter Benesh
News out of last week’s Jefferies’ global life sciences conference in NYC. IBD talks to Michael Brinkman, managing director for health care investment at Jefferies & Co.
IBD: Vaccines seem to be hot.
Brinkman: There are two – therapeutic and preventative. In preventative vaccines , one in development is the hepatitis B vaccine from Dynavax DVAX.
I guess the buying last week was from the Jefferies conference. It usually bodes well when your stock trades up after a presentation. Let’s look for volume this week to kick in and break out of this volatile triangle. A clean break of $2.00 on volume would generate quite a momentum run towards $3.00 just based on technical signals IMO.
Henryfools picks Blog 